136 related articles for article (PubMed ID: 33605970)
1. Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigen.
Rezaei F; Keshvari H; Shokrgozar MA; Doroud D; Gholami E; Khabiri A; Farokhi M
Biomater Sci; 2021 Apr; 9(7):2679-2695. PubMed ID: 33605970
[TBL] [Abstract][Full Text] [Related]
2. Silk Fibroin Nanoadjuvant as a Promising Vaccine Carrier to Deliver the FimH-IutA Antigen for Urinary Tract Infection.
Hasanzadeh S; Farokhi M; Habibi M; Shokrgozar MA; Ahangari Cohan R; Rezaei F; Asadi Karam MR; Bouzari S
ACS Biomater Sci Eng; 2020 Aug; 6(8):4573-4582. PubMed ID: 33455198
[TBL] [Abstract][Full Text] [Related]
3. Silk fibroin nanoparticles dyeing indocyanine green for imaging-guided photo-thermal therapy of glioblastoma.
Xu HL; ZhuGe DL; Chen PP; Tong MQ; Lin MT; Jiang X; Zheng YW; Chen B; Li XK; Zhao YZ
Drug Deliv; 2018 Nov; 25(1):364-375. PubMed ID: 29366360
[TBL] [Abstract][Full Text] [Related]
4. HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay.
Rezaei M; Hosseini SN; Khavari-Nejad RA; Najafi F; Mahdavi M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1543-1558. PubMed ID: 31007088
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
6. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
7. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic Potential and Therapeutic Efficacy of Multi-Epitope Encapsulated Silk Fibroin Nanoparticles against Pseudomonas aeruginosa-Mediated Urinary Tract Infections.
Rezvanirad A; Habibi M; Farokhi M; Asadi Karam MR
Macromol Biosci; 2023 Sep; 23(9):e2300074. PubMed ID: 37159936
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of Silk Scaffold Containing Simvastatin-Loaded Silk Fibroin Nanoparticles for Regenerating Bone Defects.
Mottaghitalab F; Motasadizadeh H; Shokrgozar MA; Shojaei S; Farokhi M
Iran Biomed J; 2022 Mar; 26(2):116-23. PubMed ID: 34875820
[TBL] [Abstract][Full Text] [Related]
10. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
11. Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells.
Fan X; Peng X; Wang T; Gu Y; Sun G; Shou Q; Song H; Nian R; Liu W
Biomed Mater; 2023 Jun; 18(4):. PubMed ID: 37321227
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice.
Yuan D; Yuan Q; Cui Q; Liu C; Zhou Z; Zhao H; Dun Y; Wang T; Zhang C
Can J Physiol Pharmacol; 2016 Jun; 94(6):676-81. PubMed ID: 27095502
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy.
Mottaghitalab F; Kiani M; Farokhi M; Kundu SC; Reis RL; Gholami M; Bardania H; Dinarvand R; Geramifar P; Beiki D; Atyabi F
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31600-31611. PubMed ID: 28836425
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
15. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
16. Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine.
Liu X; Min Q; Song H; Yue A; Li Q; Zhou Q; Han W
J Nanobiotechnology; 2023 Nov; 21(1):441. PubMed ID: 37993870
[TBL] [Abstract][Full Text] [Related]
17. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy of Breast Cancer by Codelivery of Doxorubicin and Survivin siRNA Using Polyethylenimine Modified Silk Fibroin Nanoparticles.
Norouzi P; Motasadizadeh H; Atyabi F; Dinarvand R; Gholami M; Farokhi M; Shokrgozar MA; Mottaghitalab F
ACS Biomater Sci Eng; 2021 Mar; 7(3):1074-1087. PubMed ID: 33539074
[TBL] [Abstract][Full Text] [Related]
20. Silk Fibroin-Coated Nano-MOFs Enhance the Thermal Stability and Immunogenicity of HBsAg.
Zhang J; Wang K; Xu S; Chen L; Gu H; Yang Y; Zhao Q; Huo Y; Li B; Wang Y; Xie Y; Li N; Zhang J; Zhang J; Li Q
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8346-8364. PubMed ID: 38323561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
